Advamed’s The MedTech Conference: We came, we saw, we connected.

22 Oct

By Max Braht, Business Development Manager, LSN

Max-Braht-HeadshotLife Science Nation (LSN) furthered its dedication to medtech by exhibiting at the world’s largest med device conference, Advamed’s MedTech in Toronto from October 14th to the 17th. The only conclusion to be drawn from the 4350 attendees, 1926 companies/exhibitors/sponsors and 550 speakers/sessions is the industry is thriving and awash with optimism, innovation and a laser-focus on patients.

For LSN, the most exciting place was the Innovation Pavilion, featuring over 30 startups, some of which had found funding from past RESI events. From medical devices to diagnostics to combination products, we found an amazing variety of innovation from otoscopes that use ultrasound to determine if a pediatric ear infection requires antibiotics or not to a new generation of home dialysis machines that prevent the common problem of infections. We were happy to extend complimentary offers to use our deep knowledge in securing capital to help these companies to fund their developmental goals. If you’re a med device startup and need help fund raising, contact us at resi@lifesciencenation.com for a complimentary review of your pitch deck and free in-depth profile of an investor who is well-aligned with your company.

MedTech Photo

On the programming front, one of the keynotes featured tennis greats and one-time rivals Chris Evert and Martina Navratilova, who gave fascinating insights into their early lives as sports stars and their current battles against cancer, and how critical imaging devices are to their treatment. Advamed did not skimp on networking receptions, providing plentiful evening opportunities to connect over Canadian gastronomic specialties and leading entertainers.

Overall, the organizers reported that MedTech 2024 was a record-breaking event for them. We certainly felt the energy of the event and plan to return next year!

RESI-London-2024-1100px

RESI-SF-2025-Banner-1100px

Leave a comment